Second of Two Parts
932 Comments Read MoreArticles
Hepatitis with a C
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More InfoWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
There is this as well from an older Regado thread:Dr. KSS, MD PhD, author of this article, says: July 31, 2014 at 4...
Yes, in fact Santarus (not Santaris) tried that very thing before Salix bought it. A pricey metformin XL. XL forms are n...
DH tweeting that ISIS negotiating Santaris settlement with Roche....smells $$$$......Is ISIS in play? Thoughts?...
To Frank Belknap and others:The Regulus news caught me by surprise, in that I have tended to check on this company a...
Could it happen to Benitec too?Roche buying Dutch Santaris, microRNA player. MicroRNA is a variant on RNAi, that we...
ICYMI @karmaswimswami this am:(1)$OXBT has given guidance that it has funds on hand sufficient to complete its multi...
Josh: My understanding is that two of the phase 2b reactions were hives, dermatologic, and that one was a hypotensive br...
Lou L: I am working at night on the second HCV installment, and I will try to cover all the companies there. If someone ...
To Nick Semuta: That HES oligonucleotide patent is just a refinement of methods now in use by Santaris (private) and Sar...
It's quite gratifying that so many people are reading and posting. I am grateful and humbled. This has become a stellar ...
I missed saying it above but meant to: Santaris's lead drug candidate (miravirsen) goes after exactly the same microRNA ...
I've been watching Regulus. They are a different play on gene silencing, going after microRNA (which is different from m...